openPR Logo

Press Releases from Graves Ophthalmopathy Therapeutics -Pharma Proff (1 total)

Graves Ophthalmopathy Therapeutics - Pipeline Analysis 2018 | Roivant Sciences, …

Graves’ ophthalmopathy is identified as an autoimmune disease in which the overproduction of thyroid hormones affects ocular and orbital tissues. According to the research studies, this disease is associated with elevated TSH receptor expression in the tissues of the orbit, with increase in the level of TSH receptor antibodies. Download the sample report @ https://www.pharmaproff.com/request-sample/1123 Graves’ ophthalmopathy is of two types: type I (lipogenic) and type II (myogenic). Type I form of

Go To Page:   1 2 3 4 5 6 7 8 9 10